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RESEARCH

Disparities in COVID-19 Rates Among
Various Demographics and Lack of Racial
Representation in Medical Texts
DiAngelo Gonzalez
Abstract
Background: The 2019 novel coronavirus (COVID-19) outbreak, which originated in Wuhan, China in
December of 2019, has impacted nations all over the globe. Given the health disparities which existed
within the United States prior to the COVID-19 pandemic, this pandemic continued to pose a significant
challenge to the health of the public. The aims of this research study were twofold: (1) to analyze the
incidence rates of COVID-19 among different racial and ethnic groups within the United States and (2) to
describe the occurrence of diversity within medical texts.
Methods: For Aim 1, a descriptive study design was utilized to identify incidence rates of COVID-19
among different racial and ethnic groups in some of the most populous counties in the United States on
April 30, 2021. Data was obtained from the public health department websites of Los Angeles, King, Clark,
Maricopa, and San Diego counties. A one-way ANOVA was used to gauge statistical significance between
these categorical variables. Further, for Aim 2, various medical texts were analyzed to gauge representation
of diverse populations within these texts. Data was obtained from the following medical texts: McMaster
Textbook of Internal Medicine, Clinical Methods 3 rd Edition: The History, Physical, and Laboratory
Examinations; and StatPearls Online Text. Within each text, word choice pertaining to either dark-skinned
patients or light-skinned patients was analyzed within chapters relating to cyanosis and pulse oximetry.
Results: Aim 1 showed a statistically significant difference between incidence rates and race as
demonstrated by the one-way ANOVA (F(5,23) = 5.5, p= 0.002). Specifically, a Tukey post hoc tested
showed that there was statistically significant difference between the following groups: White and Native
Hawaiian/ other Pacific Islander (p=0.009); Asian and Native Hawaiian/ other Pacific Islander (p=0.004);
Black and Native Hawaiian/other Pacific Islander (p=0.031); and Latino or Hispanic and Asian (p=0.038).
The data obtained for Aim 2 was not sufficient enough to conduct any meaningful statistical analyses. A
chi-square test for independence would have been used to compare the two variables to see whether the
frequencies of these categorical variables differed significantly from one another.
Conclusion: Overall, the COVID-19 pandemic exacerbated health disparities within the United States.
Understanding the magnitude of these disparities and the potential impact of medical education in reducing
them is critical in improving the health of the general population. This study sought to achieve two research
aims related to the complex intersectionality between race and disease outcomes. The data presented in this
study shows that there is a statistically significant difference between incidence rates of COVID-19 and
various racial and ethnic groups within the United States (Research Aim 1). While no statistical analyses
were able to be conducted for research Aim 2, the preliminary data shows a stark difference in word choice
used to represent dark-skinned population versus light-skinned populations. Frankly, these data show an
overall disappointing inadequacy in the representation of diverse populations expected from an increasingly
diverse nation.
Keywords: Disparities, COVID-19, Incidence rates, Demographics, Diversity, Medical Texts,
Representation, Medical Equity
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Introduction
The 2019 novel coronavirus outbreak which originated in
Wuhan, China in December of 2019 has come to impact
nations all over the globe. With existing health disparities
in the United States prior to the COVID-19 pandemic, this
pandemic continues to pose a significant risk to the public’s
health. This outbreak has been plagued by
miscommunication from government officials, including
variance in conciseness, clarity, and consistency of the
information being presented. Thus, this miscommunication
has added to public confusion and overall inaction [1]. The
evident miscommunication by government officials and the
overall misinformation present in the general public
exemplifies an overall poor response on behalf of the
United States to a situation which was constantly evolving.
This miscommunication and misinformation have not only
led to rampant spread of the virus within the United States,
but it has also led to millions of infections and hundreds of
thousands of deaths.
History of the SARS-CoV-2 Pandemic

In December 2019, an outbreak of a mysterious
respiratory illness characterized by fever, dry cough,
fatigue, and occasional gastrointestinal symptoms was
reported in Wuhan, Hubei, China [2]. Most reported
illnesses were clustered in a wholesale wet market, the
Huanan Seafood Wholesale Market. Because of the high
rate of infection among the staff (66%), the market was shut
down on January 1, 2020 after the announcement of
an epidemiological alert by the local health authority on
December 31, 2019 [2]. The alert issued by the Chinese
government on December 31, 2019 informed the World
Health Organization (WHO) about the illness induced by
the then unknown virus [3]. Within two months of
the initial outbreak in Wuhan, China, the disease spread all
over the world, reaching thousands of people in provinces
and cities within China and to other countries such
as Thailand, Japan, Republic of Korea, Vietnam, Germany,
Singapore, and the United [2]. On March 11, 2020,
the WHO declared the coronavirus disease (COVID-19) a
pandemic. The illness was identified to be caused by the
novel coronavirus, SARS-CoV-2 and had spread to over
140 countries [3]. By April 2020, the United States became
the epicenter of COVID-19 with the country recording the
highest number of officially confirmed cases of COVID-19
according to Johns Hopkins University [3].
At the time of this article, multiple variants of
COVID-19 have emerged which have continued to pose a
challenge to vaccine development. In the fall of 2020, the
United Kingdom identified a variant which spread more
easily and quickly—variant B.1.1.7. In October of 2020,
officials in South Africa identified another variant which
had similar characteristics to the U.K. variant and was
identified as variant B.1.351. At the end of January 2021,

officials conducting routine screening on travelers from
Brazil in Japan identified the Brazilian variant P.1 [4].
Within the United States, Operation Warp Speed allowed for
the rapid development of vaccines to combat the pandemic
and to date, three vaccines have been given emergency by
the Federal Drug and Food Administration (FDA): PfizerBioNTech, Moderna, and Johnson and Johnson [5, 6]. Other
vaccines which are available worldwide but have not been
given emergency authorization in the United States as of
March 28, 2021 include the AstraZeneca/Oxford COVID19 vaccine and the Sputnik V vaccine [6].
Human coronaviruses were first identified in the late
1960s, and prior to the 2003 severe acute respiratory
syndrome (SARS) outbreak in Asia, only nineteen
coronaviruses had been identified, with only two of the
nineteen being human coronaviruses [7]. The 2003 SARS
outbreak in Asia spread rapidly around the globe with a
reported 8,000 infections and 776 deaths [7]. In 2012, a
couple in Saudi Arabia was suspected to have been infected
with a
coronavirus—later
named
Middle
East
Respiratory Syndrome Coronavirus (MERS-CoV). Within
that same year, the United Kingdom identified a male who
traveled to Qatar and Saudi Arabia exhibiting symptoms of
MERS-CoV [7]. By November 2019, the WHO stated that
a total of 2,493 laboratory confirmed cases of MERSCoV were reported globally [7]. Evidently, since their
discovery,
human
coronaviruses
have
caused
much dismay and to date represent a challenge to the
public’s health due to their potential for rapid global spread
[8]. Further, these outbreaks illustrate the need for speedy
and efficient global response mobilizations in order to
protect the public’s health [8].
COVID-19 Currently

Unlike the SARS-CoV-1 epidemic, which
infected 8,100 persons in limited geographical locations
within eight months, SARS-CoV-2 managed to infect
millions of people and continues to spread rampantly around
the globe—all within a period of five months [9]. According
to Johns Hopkins University of Medicine, as of March 28,
2021, there have been 127,000,000+ confirmed cases of
COVID-19 and 2,700,000 deaths globally [10]. Within the
United States, there have been 30,260,000+ confirmed
COVID-19 cases, with 550,000 deaths [10]. Given
the basic reproductive number (R0) of COVID-19 (which
was calculated to be approximately 2.8) and the high rate of
asymptomatic transmission of the virus, COVID-19 cases
and deaths are predicted to continue to rise [9,
11]. Currently, asymptomatic transmission of COVID19 and failure of governments to adequately respond to the
virus makes the COVID-19 pandemic very difficult to
contain.
Dr. Anthony S. Fauci, who was appointed as the
director of the National Institute of Allergy and Infectious
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Diseases (NIAID) in 1984, and his colleague stated that the
past decade has seen many pandemic explosions. The two
go on to state that the COVID-19 pandemic adds evidence
to support the claim that the world has entered a pandemic
era. Fauci and his colleague acknowledge that these
situations are multifaceted, complex problems that must be
taken seriously [12].
Ultimately, with an increase in globalization,
COVID-19 is not the first and certainly won’t be the last
pandemic humanity will see. COVID-19 serves as a current
example of the severity of pathogens and the problems that
arise with their rapid spread around the globe. Given the
destruction that COVID-19 has caused since its initial
outbreak in Wuhan, China in December 2019, the world
needs governments that are ready to efficiently respond to
various outbreaks. Arguably, failure to contain SARSCoV-2 resulted from various factors, with the precipitating
factors including governments not
being
adequately
equipped to handle a rapid influx of cases in their respective
countries and a failure of governments to clearly and
concisely communicate to their citizens the severity of the
virus [1].

Differences in Attitudes, Perceptions, and Behaviors
Regarding COVID-19 Between Various Racial and
Ethnic Groups
Racial and Ethnic Disparities within the United States

Health disparities are differences in the incidence,
prevalence, mortality, and burden of diseases and other
adverse health conditions that exist among specific
population groups [13]. These disparities can stem from
health inequities, such as systematic differences in the
health of groups and communities occupying unequal and
unjust positions in society [14]. Race and ethnicity are two
major characteristics of one’s identify that can determine
the types of health outcomes a person may experience.
Weinstein et al. state that racial and ethnic disparities are
some of the most persistent inequities over the years,
despite many strides that have been made [14].
Within the United States, these health disparities
among racial and ethnic groups are extremely evident. For
example, it was found that overall mortality rates for Native
Americans are almost 50 percent higher than that of their
White counterparts, with the health and overall well-being
of Native Americans reflecting a higher risk and
higher rate of chronic diseases when compared to other
racial and ethnic groups [15]. Similarly, obesity is a
condition which has many associated chronic diseases and
debilitating conditions which overall affects racial and
ethnic minorities disproportionately. Moreover, heart
disease and cancer are the leading causes of death across
race, ethnicity, and gender, with African Americans being
30% more likely than Whites to die prematurely from heart

disease and twice as likely as Whites to die prematurely
from strokes [14].
Unfortunately,
these
health
disparities are
evident at the moment of birth for many minority
populations. It was found that for indigenous populations,
infant mortality rates are staggering. Native Americans and
Alaska Natives have infant mortality rates which are 60%
higher compared to their White counterparts [16].
Furthermore, in 2013 it was found that infants born to
African American mothers experienced disproportionate
rates of infant mortality, with the highest rate at 11.11 deaths
per 1,000 births [13]. Although the rate of low birthweight
infants remained essentially unchanged for White infants
between 2008 and 2015, the rate of low-birthweight infants
increased for African American and Hispanic infants [14]. It
is evident that health disparities exist between various racial
and ethnic groups, and although strides have been made to
close these gaps, these disparities persist to this day
COVID-19 Health Disparities Between Racial and Ethnic
Groups

These health inequalities can be exacerbated and
made more evident in times of national crises. Such was the
case with COVID-19, which has impacted every aspect of
the United States from healthcare to employment. For
example, in early April of 2020, Wisconsin and Michigan
released data which showed stark racial disparities in
rates of COVID-19 cases and deaths. In those respective
states, it was found that the percentage of affected people
who were African American was more than twice as high as
the proportion of African Americans in the overall
population [17]. This is a trend that is not unique to the
COVID-19 pandemic. In fact, with past epidemics and
natural disasters, it has been seen that some of the most
socially
marginalized
populations
will
suffer
disproportionality [17].
Furthermore, in a study published in the
Radiological Society of North America journal, researchers
sought to examine whether minority patients that were
hospitalized with COVID-19 presented with increased
severity on admission for chest x-rays when compared to
White/ non-Hispanic patients [18]. The researchers used a
retrospective cohort study and a sample size of
approximately 140 White/non-Hispanic patients and 21 nonWhite patients.
Concerningly, the researchers found that non-White
patients who were admitted to the hospital with confirmed
COVID-19 infections were more likely to present with
increased disease severity symptoms. Further, non-White
patients were also seen to have a delayed presentation (i.e.
time from presentation of symptoms to seeking care), low
English proficiency, and higher rates of obesity—all factors
which are consistent with lower socioeconomic status [18].
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In another study published in the Journal of Public
Health, researchers found that African Americans and
Hispanics had increased rates of infection and mortality
stemming from COVID-19. Although African Americans
accounted for less than a third of the population in Chicago
and Louisiana, they still represented >70% of COVID
related deaths [19]. Likewise, in New York, Hispanics
made up 29% of the population, yet they comprised 34% of
COVID related deaths [19]. These findings exemplify the
role that underlying social determinants of health,
socioeconomic disparities, and pervasive racial
disparities have in health outcomes within the United
States [19].
In light of these findings, it is important to not
report the disparities that occur within these populations
without providing an explanation as to why this may be the
case. Failure to provide explanations without the
acknowledgement of the complexities associated with these
disparities can perpetuate harmful myths and overall
misinformation that can actually undermine the goal
of eliminating health inequities [17]. Thus, in order to
avoid the harmful myths of racial biology and
behaviors associated with racial stereotypes, COVID-19
disparities need to be explained within the context of
overarching socioeconomic factors. It is important to
understand the impact that low socioeconomic status and
chronic stress brought on by racial discrimination can have
on individuals within these populations [17]. In sum, it is
central to understand the complexities behind why certain
health behaviors are practiced rather than blaming a certain
population for these behaviors for no other reason than they
belong to a certain demographic.
COVID-19 Attitudes and Perceptions Between Racial and
Ethnic Groups

Undoubtedly, the health inequities and disparities
that are seen today are exacerbated not only by COVID-19,
but also by the types of information certain populations
receive. The way in which messages are delivered affects
peoples’ ability to comprehend and trust the
information they are receiving, which ultimately influences
their enactment of these recommendations in their day to
day lives.
COVID-19 messaging from government officials,
including recommendations and guidance, has been spotty
at best. The messaging received from government officials
has varied greatly from state to state, with significant
variance in conciseness, clarity, and consistency
[1]. Multiple studies have been conducted whose aims
were to gauge knowledge, attitudes, and perceptions among
nationally representative samples of the United States
population, with significant differences being observed
between various racial and ethnic groups.

In a study by Alobuia et al. (2020), the researchers
examined recent reports which indicated racial disparities in
the rates of infection and mortality from the 2019 novel
coronavirus [19]. The researchers sought to understand
whether these disparities exist as a result of differences
in knowledge, attitudes, and practices—or any combination
of three. It was hypothesized that groups with high
knowledge scores would be more likely to have better
practices [19]. The study found that White respondents had
a median (interquartile range) knowledge score of 16,
compared with 14 among African American, Hispanic, and
Asian/ multiracial respondents. Further, compared to the
70% of White respondents with a high knowledge score,
only 25% of African American, 41% of Hispanic, and 48%
of Asian/ multiracial respondents had a high knowledge
score of COVID-19 [19]. Interestingly, the researchers
found that despite having lower average knowledge scores
and reporting more negative experiences related to COVID19, people of minority racial/ethnic backgrounds were more
likely to report engaging in better practices to reduce their
risk
of becoming infected with
COVID-19. Despite
reporting higher levels of better practices to reduce the risk
of becoming infected with the virus among minority
populations, the fact that they are disproportionately
affected by COVID-19 indicates that these imbalances
could be the result of other underlying systemic factors.
Wolf et al. (2020, p. 1) conducted a study aimed at
determining the awareness, knowledge, attitudes, and
related behaviors toward COVID-19 among adults within
the United States who were more vulnerable to
complications because of their age or comorbid conditions
[1]. The researchers utilized a cross-sectional survey linked
to three active clinical trials and one cohort study, all based
in Chicago, Illinois. It was found that African American
participants were more likely than White participants to
report that they were “not worried at all” about contracting
COVID-19 [1]. Women, African American and Hispanic
persons, those with low English proficiency, those living
below the poverty level, those with lower health literacy, and
those who were unmarried were significantly more likely to
respond that they were “not at all likely” to contract COVID19. Furthermore, adults living below the poverty level rated
COVID-19 as less serious than those with higher
incomes [1]. Overall, participants who were older, African
American, unmarried, unemployed, or retired, had poorer
health, or that had lower health literacy showed poorer
knowledge of COVID-19 and were less likely to make
changes to their everyday lives as a result of the novel
coronavirus [1]. These findings are cause for concern
because
populations
with
low
health
literacy towards COVID-19 can be more likely to spread the
virus (through
no
fault
of
their
own) and can ultimately contribute to the health disparities
and outcomes that are observed between different racial and
ethnic groups.
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Lastly, in another article published in the Journal of
Medical Internet Research, the researchers examined
similarities and differences in COVID-19 awareness and
concern by race and ethnicity [19] The researchers
conducted a cross-sectional survey between the months of
March and April. Overall, it was found that there were
differences between these populations in regard to
understanding and utilization of different COVID-19
prevention methods [20]. Specifically, it was found that
Hispanic and non-Hispanic African American participants
were more likely to report that “it was somewhat likely,
likely, or very likely” that they currently had COVID-19
compared to Asian and non-Hispanic White
participants [20]. Given that African American and
Hispanic persons were typically found to have lower health
literacy regarding COVID-19 it makes sense as to why
these two groups were more likely to believe that they were
infected with COVID—even if this was not necessarily the
case [1]. Because a lower health literacy translates to an
inability for a person to identify whether he or she is
infected with the virus, those with lower health literacies
would be unable to accurately identify symptoms and
understand how COVID-19 is spread. For example, it was
found that Asian and non-Hispanic Whites and groups with
higher health literacies were more likely to correctly
estimate the number of COVID-19 cases when compared
to African Americans and Hispanics [20].
Diversity within Medical Texts and Trainings

After review of the existing literature surrounding
COVID-19’s impact on various racial demographics,
disparities in infections and outcomes inarguably exist
within these populations. As previously mentioned,
Alobuia et al. (2020) found that although people of minority
racial and ethnic backgrounds were more likely to report
engaging in better practices to reduce their risk of becoming
infected with COVID-19, these populations were still
disproportionately affected [19]. If minority populations
are more likely to engage in safer practices to reduce their
risk of infection, then how is it possible that COVID-19 is
disproportionately affecting them? This paradox could
possibly be explained in terms of larger issues within our
healthcare infrastructure. Specifically, inadequacies in the
way our healthcare system represents people of minority
populations and those of darker skin tones.
This study will examine two ubiquitous medical
techniques employed for the identification of severe
distress in COVID-19 patients: the use of pulse oximetry
and the identification of cyanosis [21, 22]. Pulse oximetry
is a medical technology which measures arterial oxygen
saturation levels, and which indicates the percentage of
hemoglobin binding sites occupied by oxygen [22]. In
recent years, questions about pulse oximetry have been
raised, given that the original development of this
technology was aimed at populations that were not racially

diverse [23]. Regarding arterial oxygen saturation, a
common identifier of low arterial oxygen saturation is a
condition known as cyanosis—a biological response to poor
blood circulation or inadequate oxygenation of the blood
[24].
While technologies such as pulse oximetry and
diagnostic criteria such as the identification of cyanosis are
utilized to help in the reduction of morbidity and mortality
in COVID-19 patients, existing articles shows that current
racial biases exist in real-world applications and may be
furthering the disparities in COVID-19 morbidity and
mortality among minority populations. In principle, a
medical device is said to be biased when it shows
undesirable variations in performance among various
demographic groups [25]. As previously mentioned, one
such optical biosensor which uses light to monitor vital signs
is the pulse oximeter which can be used to diagnose
hypoxemia, or low levels of arterial oxygen—a symptom
indicative of severe COVID-19 manifestation [25]. To
measure blood oxygenation in a patient, a pulse oximeter
uses two colors of light: one in near-infrared and another in
visible light. However, it was found that dark skin tones
respond differently to the different wavelengths of light.
In a study involving patients receiving supplemental
oxygen at the University of Michigan Hospital and patients
in intensive care units (ICUs) at 178 hospitals, it was found
that 90 patients out of 750 had an arterial oxygen saturation
of less than 88% even though their pulse oximeter showed
an oxygen saturation of 92-96% [23]. When compared to
White patients who only showed a 3.6% difference in actual
oxygen saturation versus oxygen saturation outputted by the
pulse oximeter, 11.4% of black patients showed
inconsistencies between actual versus measured oxygen
saturation levels [19].
In addition to the use of pulse oximetry, cyanosis is
another characteristic aimed at helping to identify COVID19-related complications [26]. Although a problematic
definition, for the purpose of this study, cyanosis is defined
as a bluish discoloration of the skin resulting from poor
circulation or inadequate oxygenation of the blood. The very
fact that bluish discoloration is included in the definition of
a significantly dangerous medical condition exemplifies the
need for diversification of medical texts. In a study
published in the British Journal of Dermatology, the
researchers examined the issue of an absence of images of
skin color in publications of COVID-19 skin
manifestations—such as cyanosis [27]. Using the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA), researchers analyzed articles describing cases of
cutaneous manifestations associated with COVID-19. After
completion of the analysis, the researchers found that
cutaneous manifestations of COVID-19 showed almost
exclusively clinical images from patients with lighter skin
[27]. When looking at the physicians’ responses to their
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perceived adequacy in diversity training, 47% of patients
reported that training involving patients with darker skin
tones was inadequate and lacking [27].

Summary and Importance for Proposed Study
As depicted by these studies, it is evident that there are
differences in attitudes and perceptions regarding COVID19 between various racial and ethnic groups. It was
consistently found that minority populations, specifically
African American and Hispanic populations, exhibited
lower health literacy levels regarding COVID-19, had
lower knowledge scores, were more likely to believe they
would not contract COVID-19, and were less likely to make
changes to their everyday lives because of the pandemic [1,
17, 19, 20]. As stated earlier, it is important to not report
these findings without explanatory background as doing
so can perpetuate harmful myths and misunderstandings
regarding these specific populations. Instead, public health
officials should target material source deprivation caused
by low socioeconomic status or chronic stress brought on
by racial discrimination [17]. Being able to educate these
populations on COVID-19, including how it is spread, its
symptoms, and the seriousness of the virus will be crucial
in combatting future waves of COVID-19. It is important
to understand the complexities associated with different
demographics to help curb the spread of future outbreaks.
By understanding how different populations respond to
these outbreaks, public health officials will be able to better
target these populations in order to implement plans that are
specific to certain demographic groups.
It cannot be overstated that our medical system
needs to enter an era in which it strives to achieve medical
equity in both the technologies that are utilized and the
diagnostic processes that are implemented. Multiple studies
exist within the literature which depict flaws in the
differential diagnosis process of COVID-19 and in
fundamental technologies which are essential in the
treatment of the disease. Provided that oxygen is among the
most frequently administered medical therapies and which
is adjusted according to pulse oximetry, it is essential that
we achieve technology equity in an intentional effort to
lower disparities in poor racial health outcomes. Given that
hypoxemia is identified through pulse oximetry and is
directly related to morality, such a biased medical device
could lead to disparate outcomes for minority populations,
especially those with dark skin. Furthermore,
understanding that skin diseases manifest differently in
patients, knowledge of cutaneious manifestations of
COVID-19 (such as cyanosis) and the ability to identify
them in patients of all skin types is critical for healthcare
providers evaluating patients who may be infected with the
virus. The approach that our current medical system is
taking toward diagnosing and treating COVID-19 positive
patients will not change overnight. However, the first step

toward combatting the disparities that we’re are seeing in
COVID-19—and other diseases—is acknowledging that an
issue exists. Understanding how medical texts are teaching
the doctors of tomorrow will pave the way for equal and
equitable representation of various populations within the
medical community.

Methods
Design and Sources
Research Aim 1

Research Aim 1 utilized a descriptive study design which
identified incidence rates of COVID-19 among different
racial and ethnic groups in some of the most populous
counties in the United States on April 30, 2021. Data for this
Research Aim was obtained from the public health
department websites of the respective counties. The
following counties were analyzed: Los Angeles County,
King County, Clark County, Maricopa County, and San
Diego County. Overall, Research 1 explored the relationship
that existed between race and ethnicity as it relates to the
incidence of COVID-19.
Research Aim 2

Research Aim 2 aimed to analyze existing medical
texts in an effort to gauge representation of diverse
populations within these texts. Specifically, the following
medical texts were analyzed: McMaster Textbook of
Internal Medicine; Clinical Methods 3rd Edition: The
History, Physical, and Laboratory Examinations; and
StatPearls Online Text. Given the focus of the study, only
sections on cyanosis and pulse oximetry within these texts
were analyzed.
Data Sources
County Public Health Department Websites

Since the onset of the pandemic, public health
departments kept track of data pertaining to COVID-19,
including data on case fatality rates, incidence rates, and
hospitalization rates. As such, the counties which were
analyzed in this study all had public health department
websites which made obtaining information regarding
COVID-19 incidence rates by demographics easily
accessible.
Medical Texts

To gauge diversity representation in present day
texts, three textbooks were chosen on the basis of online
accessibility and are as follows: McMaster Textbook of
Internal Medicine; Clinical Methods 3rd Edition: The
History, Physical, and Laboratory Examinations; and
StatPearls Online Text. The McMaster Textbook of Internal
Medicine is a Canadian textbook which was developed at
McMaster University—one of the leading medical schools
in the world [28]. It is stated that the textbook was created
to meet an increasing demand for access to reliable
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information by medical professionals. Similarly, Clinical
Methods 3rd Edition: The History, Physical, and Laboratory
Examinations is a medical text which emphasizes the more
basic aspects of clinician-based practices. Given that it is
now in its third edition, the text has undergone substantial
revisions in regard to content and organization. The last text
is an online text made available by StatPearls, a company
which markets its content towards medical students and
those preparing for various medical certifications.
Key Variables
Research Aim 1

Information gathered from the websites of various
county public health departments was used to fulfill
Research Aim 1. The variable of interest was race/
ethnicity, with each county reporting its data using the
following racial/ ethnic categories: Latino/Hispanic,
American Indian/Alaska Native, Asian, Black/African
American, Native Hawaiian/ Other Pacific Islander, and
White. These categories were consistent with those found
in other governmental surveys and questionnaires,
including those in the Behavioral Risk Factor Surveillance
System [29].
Research Aim 2

Information gathered from the aforementioned texts
were used to fulfill Research Aim 2. The variable of interest
for this aim was word choice within the various texts.
Specifically, word choice pertaining to either dark skinned
patients or light skinned patients was analyzed within
chapters relating to cyanosis and pulse oximetry. Word
choices such as “darker skin pigmentation”, “people of
color”, and “deeply pigmented” are examples of phrases
representative
of
darker-skinned
populations.
Contrastingly, word choices such as “light skin” and
“bluish discoloration” are examples of phrases
representative of lighter-skinned populations.
Data Analysis
Research Aim 1

Incidence rates (per 100,000 people) for each
demographic group was obtained from the various county
public health department websites. The data from these
websites allowed for the identification in the distribution of
cases by race and ethnicity. Given that these data were
ultimately proportions, a one-way ANOVA was used to
determine if there were any statistical significances
between these categorical variables.
Research Aim 2

Data obtained for Research Aim 2 was used to
understand how often people of different skin tones were
mentioned or described in numerous medical texts. To
gauge representation in these texts, a simple frequency
count of the number of times these word choices are used

was tallied. This was compared to the number of times
phrases which are typically associated with lighter skintones were mentioned (e.g. bluish coloration).

Potential Study Limitations
Research Aim 1 and 2

With regards to study limitations, a similar limitation is
present in both research Aims 1 and 2. Utilization of data
from only five of the most populous counties provided a
very limited amount of data and may not be entirely
representative of the entire United States. Similarly, given
budget constraints and lack of access to more medical
textbooks, analyzing only three medical texts yielded
limited data and may not be representative of the training
received by medical students and others in the medical field.
Thus, this study is limited in that it may not acquire a true
snapshot of how diversity is represented in the medical field.

Study Strengths
While many articles analyzing race and ethnicity as it relates
COVID-19 are beginning to emerge, this study further adds
to the understanding of the complex dynamics of race and
COVID-19. Understanding these subtleties will allow public
health officials to better target certain demographics
throughout the United States. Furthermore, this study offers
insight into the significantly limited body of literature
surrounding diversity within medical texts and training.
Such insight is crucial in drafting texts which are
representative of the diverse communities the medical field
encounters daily.

Results
Research Aim 1

Using IBM® SPSS Statistics, a one-way ANOVA was
conducted to understand the relationship, if any, between
incidence rates and various racial groups. There was a
statistically significant difference between incidence rates
and race as demonstrated by the one-way ANOVA (F(5,23)
= 5.5, p= 0.002). Specifically, a Tukey post hoc tested
showed that there was statistically significant difference
between the following groups: white and Native Hawaiian/
other Pacific Islander (p=0.009); Asian and Native
Hawaiian/ other Pacific Islander (p=0.004); black and
Native Hawaiian/other Pacific Islander (p=0.031); and
Latino or Hispanic and Asian (p=0.038). There was no
statistically significant difference between any of the other
racial groups and their respective incidence rates.
Research Aim 2

Research Aim 2 utilized a simple frequency count
for the number of times word choices which represented
diverse populations and the number of times word choice
which represented light-colored populations was made for
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each of the respective texts. Data for this research aim was
tabulated and a bar graph depicting these differences was
created. McMaster Textbook of Internal Medicine used
word choice which represented lighter-skinned populations
four times as opposed to the one instance that word choice
which represented darker-skinned populations was used
(see figure 1). Medical Methods 3 rd Edition: The History,
Physical, and Laboratory Examinations text used word
choice which represented lighter-skinned populations 21
times as opposed to four instances that word choices which
represented darker-skinned population were used (see
figure 2). The last text used word choice which represented
lighter skinned populations 34 times as opposed to the one
instance that word choice which represented darkerskinned populations was used (see figure 3). Interestingly,
of the three texts, StatPearl’s online text was the only text
which acknowledged the inaccuracy of pulse oximetry in
darker skinned patients. As mentioned in the study
limitations section of this study, the data obtained for this
section was not sufficient enough to conduct any
meaningful statistical analyses. A chi-square test for
independence would have been used to compare the two
variables to see whether or not the frequencies of these

categorical variables differed significantly from one
another.

Conclusion
This study sought to achieve two research aims related to the
complex intersectionality between race and disease
outcomes. The data presented in this study shows that there
is a statistically significant difference between incidence
rates of COVID-19 and various racial and ethnic groups
within the United States (Research Aim 1). While no
statistical analyses were able to be conducted for research
Aim 2, the preliminary data shows a stark difference in word
choice used to represent dark-skinned population versus
light-skinned populations. Frankly, these data show an
overall disappointing inadequacy in the representation of
diverse populations expected from an increasingly diverse
nation.
Current studies in the literature exemplify
differences in the attitudes, perceptions, and behaviors
among various populations throughout the United States.
Further, it is also known that COVID-19 is affecting case,
hospitalization, and death rates among minority
populations—especially Latino and black Americans—at
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disproportionate rates. The pairing of differences in these
attitudes, perceptions, and behaviors and overall lack of
representation of minority populations in medical texts
illustrates that an overhaul of the fields responsible for
ensuring the health of the public is long overdue. Public
health and the medical field alike need to strive for
information and medical equity in order to meet the
demands of an increasingly globalized world. Further
research is needed to gauge the true extent to which
minority populations are or are not being represented in
various parts of the medical field.
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